ATE179713T1 - Verfahren zur selektiven isolierung von beta-2'- desoxy-2'2'-difluorocytidin oder seiner salze - Google Patents
Verfahren zur selektiven isolierung von beta-2'- desoxy-2'2'-difluorocytidin oder seiner salzeInfo
- Publication number
- ATE179713T1 ATE179713T1 AT94202041T AT94202041T ATE179713T1 AT E179713 T1 ATE179713 T1 AT E179713T1 AT 94202041 T AT94202041 T AT 94202041T AT 94202041 T AT94202041 T AT 94202041T AT E179713 T1 ATE179713 T1 AT E179713T1
- Authority
- AT
- Austria
- Prior art keywords
- deoxy
- difluorocytidiine
- beta
- salts
- difluoronucleosides
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 238000002955 isolation Methods 0.000 title 1
- 150000002596 lactones Chemical class 0.000 abstract 3
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Epoxy Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9072587A | 1987-08-28 | 1987-08-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE179713T1 true ATE179713T1 (de) | 1999-05-15 |
Family
ID=22224017
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95201846T ATE202113T1 (de) | 1987-08-28 | 1988-08-22 | Verfahren zur herstellung von 2'-deoxy-2',2'- difluornukleosiden |
| AT95201845T ATE217009T1 (de) | 1987-08-28 | 1988-08-22 | Stereoselektives verfahren zur herstellung von geschützten 2',2'-difluorlactonen |
| AT94202041T ATE179713T1 (de) | 1987-08-28 | 1988-08-22 | Verfahren zur selektiven isolierung von beta-2'- desoxy-2'2'-difluorocytidin oder seiner salze |
| AT88307750T ATE164847T1 (de) | 1987-08-28 | 1988-08-22 | Verfahren zur herstellung von zwischenverbindungen verwendbar in der herstellung von 2',2'-difluoronucleosiden |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95201846T ATE202113T1 (de) | 1987-08-28 | 1988-08-22 | Verfahren zur herstellung von 2'-deoxy-2',2'- difluornukleosiden |
| AT95201845T ATE217009T1 (de) | 1987-08-28 | 1988-08-22 | Stereoselektives verfahren zur herstellung von geschützten 2',2'-difluorlactonen |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88307750T ATE164847T1 (de) | 1987-08-28 | 1988-08-22 | Verfahren zur herstellung von zwischenverbindungen verwendbar in der herstellung von 2',2'-difluoronucleosiden |
Country Status (11)
| Country | Link |
|---|---|
| EP (4) | EP0688782B1 (de) |
| JP (5) | JP2738540B2 (de) |
| KR (1) | KR970002659B1 (de) |
| AT (4) | ATE202113T1 (de) |
| CA (1) | CA1324128C (de) |
| DE (4) | DE3856158T2 (de) |
| ES (4) | ES2157289T3 (de) |
| GR (1) | GR3026611T3 (de) |
| HU (3) | HU202249B (de) |
| IE (1) | IE81131B1 (de) |
| IL (1) | IL87517A (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2012129A1 (en) * | 1989-03-20 | 1990-09-20 | Ramakrishnan Nagarajan | Recovery of difluoro sugar |
| US5256797A (en) * | 1992-06-22 | 1993-10-26 | Eli Lilly And Company | Process for separating 2-deoxy-2,2-difluoro-D-ribofuranosyl alkylsulfonate anomers |
| US5401861A (en) * | 1992-06-22 | 1995-03-28 | Eli Lilly And Company | Low temperature process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates |
| US5252756A (en) * | 1992-06-22 | 1993-10-12 | Eli Lilly And Company | Process for preparing beta-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl-arylsulfonates |
| UA41261C2 (uk) * | 1992-06-22 | 2001-09-17 | Елі Ліллі Енд Компані | Спосіб одержання збагачених бета-аномером нуклеозидів |
| YU43193A (sh) * | 1992-06-22 | 1997-01-08 | Eli Lilly And Company | 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi |
| US5256798A (en) * | 1992-06-22 | 1993-10-26 | Eli Lilly And Company | Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates |
| US5559222A (en) * | 1995-02-03 | 1996-09-24 | Eli Lilly And Company | Preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose |
| JP2000501738A (ja) | 1995-12-13 | 2000-02-15 | イーライ・リリー・アンド・カンパニー | α,α―ジフルオロ―β―ヒドロキシチオールエステル及びその合成 |
| KR100578616B1 (ko) * | 2004-07-23 | 2006-05-10 | 한미약품 주식회사 | D-에리트로-2,2-다이플루오로-2-데옥시-1-옥소라이보스화합물의 제조방법 |
| EP1940859A1 (de) * | 2005-10-28 | 2008-07-09 | Arch Pharmalabs Limited | Verbessertes verfahren zur zubereitung von gemcitabinhydrochlorid |
| KR101259648B1 (ko) * | 2005-12-14 | 2013-05-09 | 동아에스티 주식회사 | 2′,2′-디플루오로뉴클레오시드 및 중간체의 새로운 제조방법 |
| KR100741310B1 (ko) * | 2006-08-01 | 2007-08-01 | (주) 유일팜테크 | 젬시타빈의 합성에 유용한 신규한나프탈렌-2-카르복실레이트 유도체와 그의 제조방법 |
| EP2139884B1 (de) * | 2007-03-23 | 2013-12-04 | Dongwoo Syntech Co., Ltd. | Verfahren zur herstellung von 2'-desoxy-2',2'-difluorcytidin |
| JP2011524369A (ja) | 2008-06-12 | 2011-09-01 | サイノファーム タイワン リミテッド | ゲムシタビン塩基の結晶多形 |
| GB0812895D0 (en) | 2008-07-15 | 2008-08-20 | Glycom As | Crystalline carbohydrate derivative |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4526988A (en) | 1983-03-10 | 1985-07-02 | Eli Lilly And Company | Difluoro antivirals and intermediate therefor |
| EP0184365B1 (de) * | 1984-12-04 | 1993-08-04 | Eli Lilly And Company | Tumorbehandlung bei Säugetieren |
| CA1295998C (en) * | 1985-07-29 | 1992-02-18 | Sai P. Sunkara | Nucleosides and their use as antineoplastic agents |
-
1988
- 1988-08-22 ES ES95201846T patent/ES2157289T3/es not_active Expired - Lifetime
- 1988-08-22 EP EP95201845A patent/EP0688782B1/de not_active Expired - Lifetime
- 1988-08-22 AT AT95201846T patent/ATE202113T1/de not_active IP Right Cessation
- 1988-08-22 EP EP94202041A patent/EP0630905B1/de not_active Expired - Lifetime
- 1988-08-22 ES ES88307750T patent/ES2113845T3/es not_active Expired - Lifetime
- 1988-08-22 DE DE3856158T patent/DE3856158T2/de not_active Expired - Lifetime
- 1988-08-22 AT AT95201845T patent/ATE217009T1/de not_active IP Right Cessation
- 1988-08-22 CA CA000575329A patent/CA1324128C/en not_active Expired - Lifetime
- 1988-08-22 AT AT94202041T patent/ATE179713T1/de not_active IP Right Cessation
- 1988-08-22 AT AT88307750T patent/ATE164847T1/de not_active IP Right Cessation
- 1988-08-22 IL IL87517A patent/IL87517A/xx not_active IP Right Cessation
- 1988-08-22 ES ES95201845T patent/ES2176279T3/es not_active Expired - Lifetime
- 1988-08-22 EP EP88307750A patent/EP0306190B1/de not_active Expired - Lifetime
- 1988-08-22 EP EP95201846A patent/EP0688783B1/de not_active Expired - Lifetime
- 1988-08-22 DE DE3856527T patent/DE3856527T2/de not_active Expired - Lifetime
- 1988-08-22 DE DE3856477T patent/DE3856477T2/de not_active Expired - Fee Related
- 1988-08-22 ES ES94202041T patent/ES2131152T3/es not_active Expired - Lifetime
- 1988-08-22 DE DE3856330T patent/DE3856330T2/de not_active Expired - Lifetime
- 1988-08-26 HU HU884471A patent/HU202249B/hu unknown
- 1988-08-26 HU HU906268A patent/HU206886B/hu unknown
- 1988-08-26 JP JP63213482A patent/JP2738540B2/ja not_active Expired - Lifetime
- 1988-08-26 IE IE260888A patent/IE81131B1/en not_active IP Right Cessation
- 1988-08-27 KR KR1019880010908A patent/KR970002659B1/ko not_active Expired - Fee Related
-
1992
- 1992-05-27 HU HU9201768A patent/HU9201768D0/hu unknown
-
1997
- 1997-08-25 JP JP9227946A patent/JP2777359B2/ja not_active Expired - Lifetime
- 1997-08-25 JP JP9227948A patent/JP2810034B2/ja not_active Expired - Lifetime
- 1997-08-25 JP JP9227952A patent/JP2899576B2/ja not_active Expired - Lifetime
- 1997-08-25 JP JP9227954A patent/JP2899577B2/ja not_active Expired - Lifetime
-
1998
- 1998-04-10 GR GR980400807T patent/GR3026611T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE179713T1 (de) | Verfahren zur selektiven isolierung von beta-2'- desoxy-2'2'-difluorocytidin oder seiner salze | |
| ATA245485A (de) | Verfahren zur herstellung von neuen dihydropyridincarbonsaeure-derivaten | |
| MY102581A (en) | Process for production of avermectins and cultures therefor | |
| DE3680800D1 (de) | Verfahren zur herstellung von (6r)-tetrahydro-l-biopterin. | |
| DE3586017D1 (de) | Stabiles glukose-isomerase-konzentrat und verfahren zu dessen herstellung. | |
| DE69839306D1 (de) | Verfahren zur herstellung und reinigung von 9-nitro-20-camptothecin | |
| DE3784988D1 (de) | Methode fuer selektiven zuwachs des anteils der gewoenlichen hauptkomponente des antibiotischen komplexes a/16686. | |
| FI884250L (fi) | Menetelmä suurien levymäisten, neulamaisten kipsikiteiden valmistamiseksi | |
| AT359191B (de) | Verfahren zur herstellung von neuen derivaten des daunorubicins | |
| DE3582368D1 (de) | Verfahren zur herstellung von epoxyden mittels mikroorganismen. | |
| AT354834B (de) | Verfahren zur verbesserung der naehrstoff- verwertung und des wachstums bei wiederkaeuern und kaninchen sowie futter- oder futterzu- satzmittel zur durchfuehrung des verfahrens | |
| DE3785266D1 (de) | Stamm zur massenproduktion von epsilon-poly-l-lysin, methode, um diesen stamm zu gebrauchen, und methode zur herstellung von epsilon-poly-l-lysin. | |
| DE3782169D1 (de) | Verfahren zur herstellung von antibiotica 10381b. | |
| DE3878580D1 (de) | Verfahren zur herstellung von kristallinen explosivstoffen. | |
| IT1206247B (it) | Metodo e composizione per migliorare il regime di crescita di animali | |
| ATE118551T1 (de) | Verfahren zur herstellung von s-2,2-r1,r2-1,3- dioxolan-4-methanol. | |
| DE69225610D1 (de) | Verfahren zur herstellung von avermectin und kulturen dafür | |
| DE3880072D1 (de) | N-phenyl-2,2,6,6-tetrahalogencyclohexanimin und verfahren zur herstellung von derivaten des 2,2,6,6-tetrahalogencyclohexanimins und von derivaten des 2,6-dihalogenanilins. | |
| ATA223587A (de) | Verfahren zur herstellung von cis-3-hydroxyprolin durch trans-cis-isomerisierung von trans-3hydroxyprolin | |
| DE3867339D1 (de) | Verfahren zur herstellung von salzen des aminomalonsaeuredinitrils. | |
| ATE58140T1 (de) | Verfahren zur herstellung eines lactons. | |
| AT378204B (de) | Verfahren zur herstellung von glucoseisomerase | |
| ATA294685A (de) | Verfahren zur herstellung von neuen nucleosidderivaten | |
| IT1209488B (it) | Destrutturizzati. procedimento per la produzione di substrati cellulosici | |
| AT378203B (de) | Verfahren zur herstellung von glucoseisomerase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |